Literature DB >> 7756992

Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP).

L E Donate1, E Gherardi, N Srinivasan, R Sowdhamini, S Aparicio, T L Blundell.   

Abstract

Plasminogen-related growth factors, a new family of polypeptide growth factors with the basic domain organization and mechanism of activation of the blood proteinase plasminogen, include hepatocyte growth factor/scatter factor (HGF/SF), a potent effector of the growth, movement, and differentiation of epithelia and endothelia, and hepatocyte growth factor-like/macrophage stimulating protein (HGF1/MSP), an effector of macrophage chemotaxis and phagocytosis. Phylogeny of the serine proteinase domains and analysis of intron-exon boundaries and kringle sequences indicate that HGF/SF, HGF1/MSP, plasminogen, and apolipoprotein (a) have evolved from a common ancestral gene that consisted of an N-terminal domain corresponding to plasminogen activation peptide (PAP), 3 copies of the kringle domain, and a serine proteinase domain. Models of the N domains of HGF/SF, HGF1/MSP, and plasminogen, characterized by the presence of 4 conserved Cys residues forming a loop in a loop, have been modeled based on disulfide-bond constraints. There is a distinct pattern of charged and hydrophobic residues in the helix-strand-helix motif proposed for the PAP domain of HGF/SF; these may be important for receptor interaction. Three-dimensional structures of the 4 kringle and the serine proteinase domains of HGF/SF were constructed by comparative modeling using the suite of programs COMPOSER and were energy minimized. Docking of a lysine analogue indicates a putative lysine-binding pocket within kringle 2 (and possibly another in kringle 4). The models suggest a mechanism for the formation of a noncovalent HGF/SF homodimer that may be responsible for the activation of the Met receptor. These data provide evidence for the divergent evolution and structural similarity of plasminogen, HGF/SF, and HGF1/MSP, and highlight a new strategy for growth factor evolution, namely the adaptation of a proteolytic enzyme to a role in receptor activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7756992      PMCID: PMC2142779          DOI: 10.1002/pro.5560031222

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  62 in total

1.  Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution.

Authors:  A M de Vos; M H Ultsch; R F Kelley; K Padmanabhan; A Tulinsky; M L Westbrook; A A Kossiakoff
Journal:  Biochemistry       Date:  1992-01-14       Impact factor: 3.162

2.  A variable gap penalty function and feature weights for protein 3-D structure comparisons.

Authors:  Z Y Zhu; A Sali; T L Blundell
Journal:  Protein Eng       Date:  1992-01

3.  Identification of a competitive HGF antagonist encoded by an alternative transcript.

Authors:  A M Chan; J S Rubin; D P Bottaro; D W Hirschfield; M Chedid; S A Aaronson
Journal:  Science       Date:  1991-11-29       Impact factor: 47.728

4.  Deletion of kringle domains or the N-terminal hairpin structure in hepatocyte growth factor results in marked decreases in related biological activities.

Authors:  K Matsumoto; T Takehara; H Inoue; M Hagiya; S Shimizu; T Nakamura
Journal:  Biochem Biophys Res Commun       Date:  1991-12-16       Impact factor: 3.575

5.  Topological similarities in TGF-beta 2, PDGF-BB and NGF define a superfamily of polypeptide growth factors.

Authors:  J Murray-Rust; N Q McDonald; T L Blundell; M Hosang; C Oefner; F Winkler; R A Bradshaw
Journal:  Structure       Date:  1993-10-15       Impact factor: 5.006

6.  Role of tryptophan-74 of the recombinant kringle 2 domain of tissue-type plasminogen activator in its omega-amino acid binding properties.

Authors:  V S De Serrano; F J Castellino
Journal:  Biochemistry       Date:  1992-04-07       Impact factor: 3.162

7.  Crystal and molecular structure of human plasminogen kringle 4 refined at 1.9-A resolution.

Authors:  A M Mulichak; A Tulinsky; K G Ravichandran
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

Review 8.  Function and evolution in the NGF family and its receptors.

Authors:  T Ebendal
Journal:  J Neurosci Res       Date:  1992-08       Impact factor: 4.164

9.  Organization of the human hepatocyte growth factor-encoding gene.

Authors:  T Seki; M Hagiya; M Shimonishi; T Nakamura; S Shimizu
Journal:  Gene       Date:  1991-06-30       Impact factor: 3.688

10.  Structure-function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding.

Authors:  N A Lokker; M R Mark; E A Luis; G L Bennett; K A Robbins; J B Baker; P J Godowski
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

View more
  44 in total

1.  Macrophage stimulating protein is a novel neurotrophic factor.

Authors:  M C Stella; A Vercelli; M Repici; A Follenzi; P M Comoglio
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

3.  PI3K is negatively regulated by PIK3IP1, a novel p110 interacting protein.

Authors:  Zhenqi Zhu; Xin He; Carla Johnson; John Stoops; Amanda E Eaker; David S Stoffer; Aaron Bell; Reza Zarnegar; Marie C DeFrances
Journal:  Biochem Biophys Res Commun       Date:  2007-04-24       Impact factor: 3.575

4.  An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.

Authors:  Kyle E Landgraf; Micah Steffek; Clifford Quan; Jeffrey Tom; Christine Yu; Lydia Santell; Henry R Maun; Charles Eigenbrot; Robert A Lazarus
Journal:  Nat Chem Biol       Date:  2014-05-25       Impact factor: 15.040

5.  The self-inhibited structure of full-length PCSK9 at 1.9 A reveals structural homology with resistin within the C-terminal domain.

Authors:  Eric N Hampton; Mark W Knuth; Jun Li; Jennifer L Harris; Scott A Lesley; Glen Spraggon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

6.  A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage.

Authors:  I Fisch; R E Kontermann; R Finnern; O Hartley; A S Soler-Gonzalez; A D Griffiths; G Winter
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

7.  The growth factor SVH-1 regulates axon regeneration in C. elegans via the JNK MAPK cascade.

Authors:  Chun Li; Naoki Hisamoto; Paola Nix; Shuka Kanao; Tomoaki Mizuno; Michael Bastiani; Kunihiro Matsumoto
Journal:  Nat Neurosci       Date:  2012-03-04       Impact factor: 24.884

Review 8.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

Review 9.  Strategies of targeting the extracellular domain of RON tyrosine kinase receptor for cancer therapy and drug delivery.

Authors:  Omid Zarei; Silvia Benvenuti; Fulya Ustun-Alkan; Maryam Hamzeh-Mivehroud; Siavoush Dastmalchi
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-08       Impact factor: 4.553

10.  Utilizing the activation mechanism of serine proteases to engineer hepatocyte growth factor into a Met antagonist.

Authors:  Daniel Kirchhofer; Michael T Lipari; Lydia Santell; Karen L Billeci; Henry R Maun; Wendy N Sandoval; Paul Moran; John Ridgway; Charles Eigenbrot; Robert A Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.